Connect your AI

Pulse Biosciences, Inc. PLSE Total Assets

Total Assets at other companies

AbbottABT

$110.43B+35.6%

Johnson & JohnsonJNJ

$200.89B+3.7%

Boston ScientificBSX

$44.35B+10.5%

MedtronicMDT

$93.03B+1.5%

Merit Medical SystemsMMSI

$2.72B+10.2%

ITG

Integer HoldingsITGR

$3.41B+3.5%

Other financials

Income statement

Revenue$401.0K—

Gross profit$31.0K—

Operating income-$19.2M-6.1%

Net income-$18.6M-10.6%

EPS (diluted)-$0.49-2.1%

Balance sheet

Cash & equivalents$68.3M-42.7%

Total debt$7.2M-16.6%

Total equity$66.3M-44.0%

Cash flow

Operating cash flow-$14.6M-7.9%

CapEx$33.0K-26.7%

Free cash flow-$14.6M-7.8%

Valuation

Market cap$1.8B+38.4%

Enterprise value$1.73B+48.1%

P/S2,391.5×—

Profitability

Gross margin-4,067.5%—

Operating margin-10,392.1%—

Net margin-9,929%—

FCF margin-7,390%—

Returns & leverage

Return on equity-80.7%+3.1pp

Debt / equity0.1×0.0×

Current ratio7.3×-8.3×

Where this comes from

Reported directly by Pulse Biosciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:Assets.

The official record: Pulse Biosciences, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Pulse Biosciences, Inc.'s total assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Pulse Biosciences, Inc.'s total assets?: Pulse Biosciences, Inc. (PLSE) reported total assets of $81.62M in Q1 2026.
How has Pulse Biosciences, Inc.'s total assets changed year-over-year?: Pulse Biosciences, Inc.'s total assets decreased by 38.8% year-over-year, from $133.38M to $81.62M.
What is the long-term trend for Pulse Biosciences, Inc.'s total assets?: Over 5 years (2020 to 2025), Pulse Biosciences, Inc.'s total assets has grown at a 18.0% compound annual growth rate (CAGR), from $41.29M to $94.54M.
What does total assets mean?: The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.